The ASTMH Annual Meeting draws tropical medicine and global health professionals representing academia, foundations, government, not for profit organizations, non-governmental organizations, the private sector, military and private practice.
Oral presentation
| Estimating the proportion of relapse following treatment of visceral leishmaniasis: Meta-analysis using Infectious Diseases Data Observatory (IDDO) living systematic review Chhajed R, Dahal P*, Singh-Phulgenda S, Brack M, Alves F, Stepniewska K, Guerin P |
Posters
| Onchocerciasis drug discovery: Evaluation of FDA-approved drugs against Onchocerca gutturosa in vitro Townson S*, Freeman A, Siemienski-Kleyn J, Zubrzycki J, Tagboto S, Scandale I, Gokool S |
| Post-kala-azar dermal leishmaniasis drug efficacy study landscape: a systematic review of clinical and observational studies to assess the feasibility of establishing an individual participant-level data platform Singh-Phulgenda S*, Kumar R, Naylor C, Munir A, Rashan S, Dahal P, Siddiqui NA, Harris E, Rahi M, Alves F, Stepniewska S, Musa A, Guérin P, Pandey K |
| A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics Tarning J*, Wattanakul T, Chotsiri P, Scandale I, Hoglund RM |
| Standardization of data with annotated case report forms for use in visceral leishmaniasis clinical trials in patients with and without HIV co-infection Naylor C*, Buck G, Singh-Phulgenda S, Brack M, Kumar R, Pandey K, Alves F, Burza S, Guérin PJ |
